Summary
Two patients with CML who developed endometrial cancer following 2 years of busulfan treatment are reported. The possibility of a causal relationship between the cytotoxic drug and the development of this malignancy is discussed.
This is a preview of subscription content, log in via an institution to check access.
References
Gusberg SB, McKay DG (1977) Malignant lesions of the corpus uteri. In: Danforth DN (ed) Obstetrics-gynecology, 3rd edn. Harper and Row, New York London, pp 955–968
Nordqvist SRB (1977) Malignant tumors of the corpus uteri. In: DeAlvarez R (ed) Textbook of gynecology, Lea and Febiger, Philadelphia, pp 290–302
Pedersen-Bjergaard J, Wissen NI, Sorensen HM, Hon-Jensen K, Larsen MS, Ernst P, Ersbol J, Knudtzon S, Rose C (1980) Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with treosulfan (=dihydroxybusulfan). Cancer 45:19–29
Penn I (1979) Leukemias and lymphomas associated with the use of cytotoxic and immunosuppressive drugs. In: Gross R, Hellriegel P (eds) Recent Results Cancer Res Strategies in Clinical Hematology. Springer, Berlin Heidelberg New York, pp 7–13
Waite DE (1981) Occupationally related carcinogenesis. Journal of AOA 80:350–355
Author information
Authors and Affiliations
Additional information
Tübitak The Unit ‘Hemolytic Anemias and Chemical Hematotoxic Disorders”
Rights and permissions
About this article
Cite this article
Aksoy, M., Erdem, S., Bakioğlu, I. et al. Endometrial cancer due to busulfan therapy. J Cancer Res Clin Oncol 108, 362–363 (1984). https://doi.org/10.1007/BF00390474
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00390474